Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants
Clinical trial NCT04504435 · TERMINATED
Trial details
- NCT number
- NCT04504435
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2024-01-14
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.